Mahmood R. Kazemi - Concepedia

Author

Mahmood R. Kazemi

Also Known As

M. Kazemi, Mahmood Kazemi, Mahmood R Kazemi, Mahmood R. Kazemi

Publications

513

Citations

H-Index

Concepts

All Affiliations

Mahmood R. Kazemi is an author at University of California, San Francisco specializing in inflammation, immunology, and autoimmunity.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	298
2	Immunology	2	2	298
3	Allergy	1	1	52
4	Biochemistry	1	1	246
5	Cell Biology	1	1	246

Mahmood R. Kazemi

Publications

503

Citations

H-Index

Page 1

	Year	Citations
Mechanisms of triglyceride accumulation in activated macrophages Kenneth R. Feingold, Judy K. Shigenaga, Mahmood R. Kazemi, Journal of Leukocyte Biology Macrophage ActivationImmunologyInflammationMetabolic SyndromeAutophagy	2012	246
Adipocyte Fatty Acid–Binding Protein Expression and Lipid Accumulation Are Increased During Activation of Murine Macrophages by Toll-Like Receptor Agonists Mahmood R. Kazemi, Carol M. McDonald, Judy K. Shigenaga, Arteriosclerosis Thrombosis and Vascular Biology	2005	143
ADRP/ADFP and Mal1 expression are increased in macrophages treated with TLR agonists Kenneth R. Feingold, Mahmood R. Kazemi, Amy L. Magra, Atherosclerosis Macrophage BiologyInflammationMolecular ImmunologyCytokineAllergy	2009	52
Hypoglycemia After Initiation of Basal Insulin in Patients with Type 2 Diabetes in the United States: Implications for Treatment Discontinuation and Healthcare Costs and Utilization Mehul Dalal, Mahmood R. Kazemi, Fen Ye, Advances in Therapy	2017	33
Achieve control: a pragmatic clinical trial of insulin glargine 300 U/mL versus other basal insulins in insulin-naïve patients with type 2 diabetes Gerry Oster, Sean D. Sullivan, Mehul Dalal, Postgraduate Medicine	2016	15
Hypoglycemia in patients with type 2 diabetes newly initiated on basal insulin in the US in a community setting: impact on treatment discontinuation and hospitalization Mehul Dalal, Mahmood R. Kazemi, Fen Ye Current Medical Research and Opinion	2016	14

Page 1